Organon (OGN) closed the most recent trading day at $16.26, moving +1.82% from the previous trading session. This change outpaced the S&P 500's 1.46% loss on the day. On the other hand ...

Organon (NYSE:OGN) is scheduled to announce Q4 earnings results on Thursday, February 13th, before market open. Analysts expect a profit of $0.87 per share (-1.1% Y/Y) on revenue of $1.59B (-0.5% ...

It focuses therapeutics in women’s health, biosimilars, and established brands. OGN is truly a diversified global company, with a presence in 140 markets and three-quarters of revenues coming ...

Organon (OGN) closed at $14.62 in the latest trading session, marking a -1.81% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.95%. Meanwhile, the Dow ...

Organon (OGN) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.88 per share a year ago. These figures ...

In this article, we are going to take a look at where Organon & Co. (NYSE:OGN) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase “defensive” as ...

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Organon beat analysts’ revenue expectations by 1.1% last ...

In a report released today, Jason Gerberry from Bank of America Securities reiterated a Sell rating on Organon (OGN – Research Report). The company’s shares closed yesterday at $16.32.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organon (OGN) reported $1.59 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 0.4%. EPS of $0.90 for the same period compares to $0.88 a year ago.